Patent details

Basic Information

Publication number:

EP2170292

PCT Application Number:

PCT/US/2008/067622

Type:

European Patent Granted for LU

Legal Status:

In force

Application number:

EP087715629

PCT Publication Number:

WO/2009/002821

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

TABLETED COMPOSITIONS CONTAINING ATAZANAVIR

French Title of Invention:

COMPOSITIONS CONTENANT DE L'ATAZANAVIR MISES SOUS FORME DE COMPRIMÉS

German Title of Invention:

TABLETTIERTE ATAZANAVIRHALTIGE ZUSAMMENSETZUNGEN

SPC Number:

Dates

Filing date:

20/06/2008

Grant date:

08/01/2014

EP Publication Date:

08/01/2014

PCT Publication Date:

31/12/2008

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

07/04/2010

EP B1 Publication Date:

08/01/2014

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

Expiration date:

20/06/2028

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

23/01/2019

 

 

Name:

Bristol-Myers Squibb Holdings Ireland Unlimited Company

Address:

Hinterbergstrasse 16, 6312, Steinhausen, Switzerland (CH)

History of Owners

From:

23/01/2019

To:

23/01/2019

Name:

Bristol-Myers Squibb Holdings Ireland

Address:

Hinterbergstrasse 16, Steinhausen, Switzerland (CH)

From:

20/06/2008

To:

23/01/2019

Name:

Bristol-Myers Squibb Holdings Ireland

Address:

Neuhofstrasse 6, 6340 Baar, Switzerland (CH)

Agent

Name:

MARKS & CLERK LLP

From:

07/02/2014

Address:

BP 1775, 1017, LUXEMBOURG, Luxembourg (LU)

To:

Inventor

1

Name:

KOO Otilia, May, Yue

Address:

United States (US)

2

Name:

NIKFAR Faranak

Address:

United States (US)

3

Name:

DIAZ Steven

Address:

United States (US)

Priority

Priority Number:

945701 P

Priority Date:

22/06/2007

Priority Country:

United States (US)

Classification

Main IPC Class:

A61K 9/20;

Publication

Bulletin

1

Bulletin Heading:

CO

Bulletin edition number:

2019/02

Publication date:

22/02/2019

Description:

Section M : Transfers of property (Art. 53 of the law), change of name and/or address

2

Bulletin Heading:

CO

Bulletin edition number:

2019/02

Publication date:

22/02/2019

Description:

Section M : Transfers of property (Art. 53 of the law), change of name and/or address

Deed

Change of owner(s)

Change Kind/ Decision Type:

Change of owner(s) name/address

Deed Number:

RC20190000044A

Date Registered:

23/01/2019

Licence Effective Date:

Licence Expiration Date:

Scope of Licence:

Deed Filer:

OFFICE FREYLINGER S.A.

Journal Edition Number:

Text:

Changement d'adresse

Country Code:

Updated Licence Number:

Terminated Licence Number:

Added Owner(s)

Name:

Bristol-Myers Squibb Holdings Ireland

Address:

Hinterbergstrasse 16, Steinhausen, Switzerland (CH)

Removed Pledgee

Name:

Address:

Change of owner(s)

Change Kind/ Decision Type:

Change of owner(s) name/address

Deed Number:

RC20190000045A

Date Registered:

23/01/2019

Licence Effective Date:

Licence Expiration Date:

Scope of Licence:

Deed Filer:

OFFICE FREYLINGER S.A.

Journal Edition Number:

Text:

Country Code:

Updated Licence Number:

Terminated Licence Number:

Added Owner(s)

Name:

Bristol-Myers Squibb Holdings Ireland Unlimited Company

Address:

Hinterbergstrasse 16, 6312, Steinhausen, Switzerland (CH)

Removed Pledgee

Name:

Address:

Annual Fees

Annual Fee Due Date:

30/06/2026

Annual Fee Number:

19

Annual Fee Amount:

281 Euro

Expected Payer:

Last Annual Fee Payment Date:

11/06/2025

Last Annual Fee Paid Number:

18

Last Annual Fee Paid Amount:

262 Euro

Payer:

CPA GLOBAL THE IP PLATFORM

Filing date	Document type	Number of pages
23/01/2019	Request For Change	6
23/01/2019	Outgoing Correspondence	1
23/01/2019	Outgoing Correspondence	1
23/01/2019	Request For Change	1
12/08/2022	Request For Change	1
02/09/2022	Outgoing Correspondence	56